Clinical Trial Update: Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares the safety and efficacy of lumiracoxib versus naproxen for acute musculoskeletal pain. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Musculoskeletal Pain

Drugs mentioned

• Lumiracoxib (Lumiracoxib)
• Naproxen (Naproxen)

Snippet

Sponsor: Novartis | Conditions: Musculoskeletal Pain | Phase 4 | Status: COMPLETED